The biotech company, which specializes in research into natural solutions for the early treatment of metabolic disorders, will present preclinical results on pre-diabetes in San Diego from June 23 to … Read more
Inato raises $20 million to make clinical trials more inclusive On March 9, 2023, Iktos, a company established in 2016 and specializing in the use of artificial intelligence to discover … Read more
The Colibri industrial research fellowship was inaugurated on April 4, 2023. It brings together Rouen Normandy INSA, the CNRS, the University of Rouen and Oril Industrie. Develop effective and innovative … Read more
For the last five years, the French laboratory Pierre Fabre has been engaged in significant expansion in the field of oncology via successful partnerships with US biotech companies. Its sales … Read more
These startups and associations in the French health ecosystem received awards in March 2023 for their inventiveness and innovations. As part of the Plan National Santé-Environnement 4 designed to stimulate development … Read more
With these two new units, which will be built in Toulouse by mid-2023, the CDMO will be the only one in France offering GMP development and manufacturing services on a … Read more
The new consortium, which brings together different public and specialized private AI and oncology operators, aims to turn France into a global leader in the use of AI to diagnose … Read more
The ANRS and a number of French public operators launched two PRISME platforms at the start of 2023 to encourage exchanges of ideas in scientific research and training. Co-operation between … Read more
In addition to a grant of €2.5 million awarded on March 30 by the EIC, Smart Immune has announced that the renowned US foundation has acquired a €5 million stake … Read more
The world’s second largest producer of monoclonal antibodies in immuno-hematology has been awarded €6.5 million from the French state as part of the France 2030 Plan. The French specialist in … Read more
A delegation of the French research organization was in San Francisco from February 28 to March 2, 2023 to share ideas with researchers from the UCSF QBI (University of California, … Read more
The medtech company established by Professor Alexandre Carpentier has just finished Phase 2 of the clinical trial for its device designed to treat recurrent glioblastoma and is about to start … Read more